<http://schema.org/description>
"Repros Therapeutics share price has been on a declining trend ever since the company received guidance from the FDA related to the Androxal development program."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/113984/loss-narrows-at-repros-shares-down>